As per the current market research conducted by the CMI Team, the global Non-Invasive Blood Glucose Monitoring Devices Market size is expected to record a CAGR of 23% from 2023 to 2032. In 2022, the market size is projected to reach a valuation of USD 25 million. By 2032, the valuation is anticipated to reach USD 169.33 million.

Non-Invasive Blood Glucose Monitoring Devices Market: Growth Factors and Dynamics

  • Growing Diabetes Prevalence: The substantial rise in diabetes cases globally, spanning all age groups, is a fundamental driving force behind the market’s expansion. The need for accurate and convenient glucose monitoring solutions is intensifying, propelling the adoption of non-invasive devices.
  • Advancements in Technology: Rapid technological progress is transforming the landscape of non-invasive blood glucose monitoring. Innovations such as spectroscopy-based methods, wearable sensors, and wireless connectivity are enhancing device accuracy, ease of use, and data accessibility.
  • Patient-Centric Healthcare: The shift towards patient-centric healthcare is encouraging the development of solutions that empower individuals to actively manage their health conditions. Non-invasive blood glucose monitoring aligns with this trend by providing hassle-free and continuous monitoring options.
  • Continuous Monitoring: The ability of non-invasive devices to offer real-time and continuous glucose monitoring presents a paradigm shift in diabetes management. This dynamic approach enables proactive adjustments to treatment plans based on immediate data insights.
  • Healthcare Accessibility: Non-invasive blood glucose monitoring devices contribute to improved healthcare accessibility, particularly in regions with limited healthcare infrastructure. Patients can monitor their glucose levels conveniently at home, reducing the need for frequent clinic visits.
  • Aging Population: The aging global population is more prone to diabetes, creating a demand for user-friendly monitoring solutions. Non-invasive devices cater to older individuals who may experience challenges with traditional methods.

Report Scope

Feature of the ReportDetails
Market Size in 2023USD 39.43 Million
Projected Market Size in 2032USD 169.33 Million
Market Size in 2022USD 25 Million
CAGR Growth Rate23% CAGR
Base Year2023
Forecast Period2024-2033
Key SegmentBy Technology, Modality, End-Use and Region
Report CoverageRevenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional ScopeNorth America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying OptionsRequest tailored purchasing options to fulfil your requirements for research.

Non-Invasive Blood Glucose Monitoring Devices Market: COVID-19 Analysis

  • Demand for Remote Monitoring: The pandemic highlighted the importance of remote healthcare solutions. Non-invasive blood glucose monitoring devices, which allow patients to monitor their glucose levels at home, gained traction as individuals sought to minimize their exposure to healthcare facilities.
  • Telehealth Integration: The integration of non-invasive monitoring with telehealth platforms surged during the pandemic. Healthcare providers embraced virtual consultations, and patients could share their real-time glucose data, facilitating more informed remote medical guidance.
  • Patient-Centric Care: The pandemic underscored the significance of patient-centric care. Non-invasive devices offered patients a safer and more convenient means of monitoring their health, aligning with the evolving preferences of healthcare consumers.
  • Supply Chain Disruptions: Like many industries, the medical device sector faced supply chain disruptions due to lockdowns and restrictions. This impacted the availability and production of non-invasive blood glucose monitoring devices, leading to potential delays.
  • Economic Factors: Economic uncertainties prompted individuals to seek cost-effective healthcare solutions. Non-invasive devices, which provide painless monitoring without the need for disposable supplies, gained appeal as patients aimed to manage their health efficiently.
  • Rise in Chronic Conditions: The pandemic heightened awareness about the importance of managing underlying health conditions. Non-invasive blood glucose monitoring devices gained attention as people recognized the significance of proactively managing diabetes.

Global Non-Invasive Blood Glucose Monitoring Devices Market 2023–2032 (By Million)

List of the prominent players in the Non-Invasive Blood Glucose Monitoring Devices Market:

  • Abbott Laboratories
  • CNOGA Medical Ltd.
  • DiaMonTech AG
  • Metamaterial Technologies Inc. (GlucoWise)
  • Nemaura Medical
  • Integrity Applications
  • BOYDSense Inc.
  • RSP Systems
  • AerBetic
  • LifePlus Inc.
  • Others

The Non-Invasive Blood Glucose Monitoring Devices Market is segmented as follows:

By Technology

  • MIR/NIR (Mid/Near-Infrared Spectroscopy)
  • Raman Spectroscopy
  • Occlusion Spectroscopy
  • Optical Coherence Tomography
  • Thermal Emission Spectroscopy
  • Photoacoustic Spectroscopy
  • Impedance/Dielectric Spectroscopy
  • Electromagnetic
  • Others

By Modality

  • Wearable Blood Glucose Monitoring Systems
  • Non-wearable /Table-top Blood Glucose Monitoring Systems

By End-Use

  • Hospitals
  • Home Care Settings
  • Clinics
  • Others

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America


  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America